Accunea

Accunea operates in the health technology and medical device industry, focusing on organ transplantation. The company develops point-of-care diagnostics and continuous organ function monitoring technology designed to improve kidney transplant outcomes. Its RenoSure device monitors biomarkers linked to kidney function and metabolism in real time, supporting clinicians before and after transplantation. Accunea’s services include pre-transplant viability assessment, post-operative monitoring, AI-assisted trend analysis, early warning insights and integration with hospital electronic patient record systems. Its technology aims to reduce organ discard rates, support safer clinical decision-making and help more patients receive viable donated kidneys.